Jasper Therapeutics(JSPR)
Search documents
Jasper Therapeutics(JSPR) - 2020 Q3 - Quarterly Report
2020-11-10 22:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39138 AMPLITUDE HEALTHCARE ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) D ...
Jasper Therapeutics(JSPR) - 2020 Q2 - Quarterly Report
2020-08-14 00:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39138 AMPLITUDE HEALTHCARE ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) Delaware 84-2984849 (S ...
Jasper Therapeutics(JSPR) - 2020 Q1 - Quarterly Report
2020-05-13 21:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (MARK ONE) FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39138 AMPLITUDE HEALTHCARE ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Delaware | 84-2984849 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 1177 A ...
Jasper Therapeutics(JSPR) - 2019 Q4 - Annual Report
2020-03-26 20:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39138 AMPLITUDE HEALTHCARE ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Delaware | | 84-2984849 | | --- | --- ...